Henry, LP, Amminger, GP, Harris, MG, Yuen, HP, Harrigan, SM, Prosser, AL, et al. The EPPIC follow-up study of first-episode
psychosis: longer-term clinical and functional outcome 7 years after
index admission. J Clin Psychiatry
2010; 71: 716–28.
Chen, CH, Shen, YC, Zhang, WX, Li, SR, Huang, YQ, Wang, JR, et al. Epidemiological survey on schizophrenia in 7
areas of China [in Chinese]. Chin J
1998; 31: 72–4.
Ferrari, AJ, Saha, S, McGrath, JJ, Norman, R, Baxter, AJ, Vos, T, et al. Health states for schizophrenia and bipolar
disorder within the Global Burden of Disease 2010 Study.
Popul Health Metr
2012; 10: 1.
Olivares, JM, Sermon, J, Hemels, M, Schreiner, A. Definitions and drivers of relapse in patients with
schizophrenia: a systematic literature review.
Ann Gen Psychiatry
2013; 12: 32.
Ascher-Svanum, H, Faries, DE, Zhu, B, Ernst, FR, Swartz, MS, Swanson, JW. Medication adherence and long-term functional
outcomes in the treatment of schizophrenia in usual care.
J Clin Psychiatry
2006; 67: 453–60.
Wykes, T, Steel, C, Everitt, B, Tarrier, N. Cognitive behavior therapy for schizophrenia: effect
sizes, clinical models, and methodological rigor.
2008; 34: 523–37.
National Institute for Health and Care Excellence.
Core Interventions in the Treatment and Management of
Schizophrenia in Adults in Primary and Secondary Care.
National Collaborating Centre for Mental
Kreyenbuhl, J, Buchanan, RW, Dickerson, FB, Dixon, LB. The schizophrenia patient outcomes research team
(PORT): updated treatment recommendations 2009.
Li, ZJ, Guo, ZH, Wang, N, Xu, ZY, Qu, Y, Wang, XQ, et al. Cognitive-behavioural therapy for patients
with schizophrenia: a multicentre randomized controlled trial in Beijing,
China. Psychol Med
2015; 45: 1893–905.
Xiang, Y-T, Weng, Y-Z, Li, W-Y, Gao, L, Chen, G-L, Xie, L, et al. Efficacy of the Community Re-Entry Module for
patients with schizophrenia in Beijing, China: outcome at 2-year
follow-up. Br J Psychiatry
Turkington, D, Kingdon, D, Turner, T. Effectiveness of a brief cognitive–behavioural
therapy intervention in the treatment of schizophrenia.
Br J Psychiatry
2002; 180: 523–7.
Turkington, D, Kingdon, D, Rathod, S, Hammond, K, Pelton, J, Mehta, R. Outcomes of an effectiveness trial of
cognitive–behavioural intervention by mental health nurses in
schizophrenia. Br J Psychiatry
Waller, H, Garety, PA, Jolley, S, Fornells-Ambrojo, M, Kuipers, E, Onwumere, J, et al. Low intensity cognitive behavioural therapy
for psychosis: a pilot study. J Behav Ther Exp
World Health Organization. The ICD-10
Classification of Mental and Behavioural Disorders: Clinical Descriptions
and Diagnostic Guidelines.
Kay, SR, Fiszbein, A, Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for
schizophrenia. Schizophr Bul
1987; 13: 261–76.
Guo, ZH, Li, ZJ, Ma, Y, Zhou, YL, Chao, WM, Guo, JH, et al. A pilot study on the effect of brief
cognitive behavioural therapy combined with routine treatment for
schizophrenia in communities of Beijing [in Chinese].
Chin J Psychiatry
2015; 48: 331–8.
Chen, M, Wu, G, Wang, Z, Yan, J, Zhou, J, Ding, Y, et al. Two-year prospective case-controlled study of
a case management program for community-dwelling individuals with
schizophrenia. Shanghai Arch Psychiatry
2014; 26: 119–28.
David, AS. Insight and psychosis. Br J
Si, TM, Yang, JZ, Shu, L, Wang, XL, Kong, QM, Zhou, M, et al. The reliability, validity of PANSS and its
implications [in Chinese]. Chin Ment
2004; 18: 45–7.
Xu, ZY, Guo, ZH, Fu, ZY, Wang, N, Zhang, Y. Reliability and validity of the Chinese version of
the schedule for assessment of insight [in Chinese].
Chin J Behav Med Brain Sci
2013; 22: 752–4.
Morosini, P, Magliano, L, Brambilla, L, Ugolini, S, Pioli, R. Development, reliability and acceptability of a new
version of the DSM-IV Social and Occupational Functioning Assessment
Scale (SOFAS) to assess routine social functioning.
Acta Psychiatr Scand
2000; 101: 323–9.
Tianmei, S, Liang, S, Yun'ai, S, Chenghua, T, Jun, Y, Jia, C, et al. The Chinese version of the Personal and
Social Performance Scale (PSP): validity and reliability.
2011; 185: 275–9.
Beck, AT, Steer, RA, Ball, R, Ranieri, W. Comparison of Beck Depression Inventories-IA and -II
in psychiatric outpatients. J Pers
1996; 67: 588–97.
Wang, Z, Yuan, CM, Huang, J, Li, ZZ, Chen, Y, Zhang, HY, et al. Reliability and validity of the Chinese
version of Beck Depression Inventory-II among depression patients [in
Chinese]. Chin Ment Health
2011; 25: 476–80.
Cohen, J. A power primer. Psychol
1992; 112: 155–9.
Pinson, L, Gray, GE. Psychopharmacology: number needed to treat: an
underused measure of treatment effect. Psychiatr
2003; 54: 145–6.
Lehman, AF, Lieberman, JA, Dixon, LB, McGlashan, TH, Miller, AL, Perkins, DO, et al. Practice guideline for the treatment of
patients with schizophrenia, second edition. Am J
2004; 161 (suppl 2):
Morrison, AP, Turkington, D, Pyle, M, Spencer, H, Brabban, A, Dunn, G, et al. Cognitive therapy for people with
schizophrenia spectrum disorders not taking antipsychotic drugs: a
single-blind randomised controlled trial.
2014; 383: 1395–403.
Tarrier, N, Yusupoff, L, Kinney, C, McCarthy, E, Gledhill, A, Haddock, G, et al. Randomised controlled trial of intensive
cognitive behaviour therapy for patients with chronic
1998; 317: 303–7.
Zimmermann, G, Favrod, J, Trieu, V, Pomini, V. The effect of cognitive behavioral treatment on the
positive symptoms of schizophrenia spectrum disorders: a
meta-analysis. Schizophr Res
Freeman, D, Dunn, G, Startup, H, Pugh, K, Cordwell, J, Mander, H, et al. Effects of cognitive behaviour therapy for
worry on persecutory delusions in patients with psychosis (WIT): a
parallel, single-blind, randomised controlled trial with a mediation
analysis. Lancet Psychiatry
2015; 2: 305–13.
Hansen, L, Turkington, D, Kingdon, D, Smith, P. Brief rating instrument for assessment of negative
symptoms: derived from the Comprehensive Psychopathological Rating Scale
(CPRS). Int J Psychiatry Clin Pract
2003; 7: 113–6.
Rathod, S, Kingdon, D, Smith, P, Turkington, D. Insight into schizophrenia: the effects of cognitive
behavioural therapy on the components of insight and association with
sociodemographics—data on a previously published randomised controlled
trial. Schizophr Res
2005; 74: 211–9.
Gerlinger, G, Hauser, M, De Hert, M, Lacluyse, K, Wampers, M, Correll, CU. Personal stigma in schizophrenia spectrum disorders:
a systematic review of prevalence rates, correlates, impact and
interventions. World Psychiatry
2013; 12: 155–64.
Bedford, NJ, David, AS. Denial of illness in schizophrenia as a disturbance
of self-reflection, self-perception and insight.
Iqbal, Z, Birchwood, M, Chadwick, P, Trower, P. Cognitive approach to depression and suicidal
thinking in psychosis 2. Testing the validity of a social ranking
model. Br J Psychiatry
2000; 177: 522–8.
Granholm, E, McQuaid, JR, McClure, FS, Link, PC, Perivoliotis, D, Gottlieb, JD, et al. Randomized controlled trial of cognitive
behavioral social skills training for older people with schizophrenia:
12-month follow-up. J Clin Psychiatry
2007; 68: 730–7.
Grant, PM, Huh, GA, Perivoliotis, D, Stolar, NM, Beck, AT. Randomized trial to evaluate the efficacy of
cognitive therapy for low-functioning patients with
schizophrenia. Arch Gen Psychiatry
2012; 69: 121–7.
Lecomte, T. Psychosis patients refusing antipsychotic medicine
could benefit from CBT in terms of both symptom reduction and social
functioning. Evid Based Ment Health
2015; 18: 18.
Tarrier, N, Lewis, S, Haddock, G, Bentall, R, Drake, R, Kinderman, P, et al. Cognitive–behavioural therapy in
first-episode and early schizophrenia: 18-month follow-up of a randomised
controlled trial. Br J Psychiatry
2004; 184: 231–9.
Blackburn, IM, James, IA, Milne, DL, Baker, C, Standart, S, Garland, A, et al. The revised cognitive therapy scale (CTS-R):
psychometric properties. Behav Cogn
2001; 29: 431–46.